SCHEMBL28049475

SCHEMBL28049475

CC(=O)Oc1cnc(N)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
F2 P00734 1/20 0.45
GLA P06280 1/20 0.45
HPGD P15428 1/20 0.45
LMNA P02545 4/20 0.43
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
CYP19A1 P11511 1/20 0.40
MAPT P10636 3/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
CYP3A4 P08684 3/20 0.38
ELANE P08246 1/20 0.38
HSD17B10 Q99714 1/20 0.37
KDM4E B2RXH2 3/20 0.37
ABCB11 O95342 1/20 0.37
ESR1 P03372 1/20 0.37
ADRA2A P08913 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL186176 0.84 HDAC1 (0.42) ALDH1A1F2GLAHPGDLMNA
SCHEMBL24786404 0.80 LMNA (0.50) ALDH1A1F2GLAHPGDLMNA
SCHEMBL29225190 0.80 KMT2A (0.45) HDAC1HDAC6TSHRADRA1AHSP90AA1
SCHEMBL10588692 0.79 HDAC1 (0.42) ALDH1A1F2GLAHPGDLMNA
SCHEMBL27337562 0.79 ALDH1A1 (0.50) ALDH1A1F2GLAHPGDLMNA
SCHEMBL21612934 0.78 ALDH1A1 (0.45) ALDH1A1F2GLAHPGDLMNA
SCHEMBL25405562 0.78 ALDH1A1 (0.45) ALDH1A1F2GLAHPGDLMNA
SCHEMBL10610539 0.76 ALDH1A1 (0.47) ALDH1A1F2GLAHPGDLMNA
SCHEMBL27503300 0.75 THRB (0.40) HDAC1HDAC6HSP90AA1SMN1; SMN2FLT3
SCHEMBL27794951 0.75 ALDH1A1 (0.42) ALDH1A1F2GLAHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105254634-A SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER PHARMACEUTICALS CORP 2016-01-20 CN disclosed